Carboplatin 10 mg/mL (Carboplatin INJECTION) 10 mg/mL

Carboplatin 10 mg/mL is an injectable medication used for various therapeutic purposes. This multi-dose vial is suitable for intravenous administration and is manufactured by Accord Healthcare, Inc.

Strength

10 mg/mL

Pack Size

1 VIAL, MULTI-DOSE in 1 CARTON (16729-295-33) / 15 mL in 1 VIAL, MULTI-DOSE

Manufacturer / TM Owner

Accord Healthcare, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Carboplatin 10 mg/mL is commonly used in the treatment of certain types of cancer. It works by interfering with the growth of cancer cells, making it a key component in chemotherapy regimens. Patients often wonder, 'What is Carboplatin used for?' and the answer lies in its ability to target and slow the progression of malignant cells.

Side Effects

When administered intravenously, Carboplatin 10 mg/mL may cause common side effects such as nausea, vomiting, and fatigue. These effects can vary from person to person and are typically managed under medical supervision. It's important to discuss any concerns with a healthcare provider.

Precautions & Warnings

Carboplatin 10 mg/mL should be handled with care, as it is a potent medication. It is essential to follow proper storage and administration guidelines to ensure safety. Patients should be monitored regularly for any adverse reactions, and precautions should be taken to avoid contamination.

Avoid Interactions

Carboplatin 10 mg/mL may interact with other medications, including certain antibiotics and other chemotherapy drugs. It is crucial to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and other substances may also affect the efficacy and safety of Carboplatin.

Frequently Asked Questions

Carboplatin is primarily used in the treatment of various types of cancer, often as part of a chemotherapy regimen.

Carboplatin 10 mg/mL is administered intravenously, typically under the supervision of a healthcare professional.

Common side effects may include nausea, vomiting, and fatigue, though individual experiences can vary.

Yes, Carboplatin may interact with other medications, including certain antibiotics and other chemotherapy drugs.

Carboplatin 10 mg/mL should be stored according to the manufacturer's guidelines to maintain its efficacy and safety.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.